ArticleNature communications2022

Immunosuppressive biomaterial-based therapeutic vaccine to treat multiple sclerosis via re-establishing immune tolerance.

Thanh Loc Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.